Therapeutic drug monitoring (TDM) in children and adolescents during sertraline therapy

被引：0
|
作者：
Klampfl, K. [1 ]
Fleischmann, Y. [1 ]
Wewetzer, Ch [2 ]
Pfuhlmann, B. [3 ,4 ]
Mehler-Wex, C. [5 ]
Gerlach, M. [1 ]
机构：
[1] Univ Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, Wurzburg, Germany
[2] Clin City Cologne GmbH, Child & Adolescent Psychiat & Psychotherapy, Cologne, Germany
[3] Univ Wurzburg, Lab Therapeut Drug Monitoring, Psychiat Clin, Wurzburg, Germany
[4] Univ Wurzburg, Lab Therapeut Drug Monitoring, Clin Psychosomat & Psychotherapy, Wurzburg, Germany
[5] Univ Ulm, Dept Child & Adolescent Psychiat & Psychotherapy, D-89069 Ulm, Germany
来源：
PHARMACOPSYCHIATRY | 2011年 / 44卷 / 06期
关键词：
D O I：
10.1055/s-0031-1292290
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Therapeutic drug monitoring (TDM) of fluoxetine in children and adolescents
    Koelch, M.
    Pfalzer, A.
    Keller, F.
    Plener, P.
    Gerlach, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S608 - S609
  • [2] Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
    Hansen, D.
    Taurines, R.
    Wewetzer, C.
    Pfuhlmann, B.
    Plener, P.
    Mehler-Wex, C.
    Gerlach, M.
    Egberts, K.
    PHARMACOPSYCHIATRY, 2012, 45 (06) : 253 - 253
  • [3] Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial
    Frey, Michael
    Smigielski, Lukasz
    Tini, Elvira
    Fekete, Stefanie
    Fleischhaker, Christian
    Wewetzer, Christoph
    Karwautz, Andreas
    Correll, Christoph U.
    Gerlach, Manfred
    Taurines, Regina
    Plener, Paul L.
    Malzahn, Uwe
    Kornbichler, Selina
    Weninger, Laura
    Brockhaus, Matthias
    Reuter-Dang, Su-Yin
    Reitzle, Karl
    Rock, Hans
    Imgart, Hartmut
    Heuschmann, Peter
    Unterecker, Stefan
    Briegel, Wolfgang
    Banaschewski, Tobias
    Fegert, Joerg M.
    Hellenschmidt, Tobias
    Kaess, Michael
    Koelch, Michael
    Renner, Tobias
    Rexroth, Christian
    Walitza, Susanne
    Schulte-Koerne, Gerd
    Romanos, Marcel
    Egberts, Karin Maria
    Magni, Paolo
    PHARMACEUTICS, 2023, 15 (09)
  • [4] Therapeutic drug monitoring (TDM)
    Pokrajac, M
    JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 1998, 17 (03): : 159 - 159
  • [5] TDM: Therapeutic drug measuring or therapeutic drug monitoring?
    Droste, JAH
    Koopmans, PP
    Hekster, YA
    Burger, DM
    THERAPEUTIC DRUG MONITORING, 2005, 27 (04) : 412 - 416
  • [6] Therapeutic drug monitoring (TDM) for improvement of an antipsychotic therapy with amisulpride
    Hiemke, C
    Vernaleken, I
    Gründer, G
    Härtter, S
    Müller, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S418 - S418
  • [7] Fluvoxamine serum concentrations in children and adolescents - preliminary results of a multicenter Therapeutic Drug Monitoring (TDM) trial
    Taurines, R.
    Kunkel, G.
    Fekete, S.
    Gerlach, M.
    Romanos, M.
    Egberts, K.
    PHARMACOPSYCHIATRY, 2024, 57 (02) : 93 - 93
  • [8] THERAPEUTIC DRUG MONITORING (TDM) DURING PREGNANCY AND BREAST FEEDING
    Conca, A.
    Bergemann, N.
    Waschgler, R.
    Adami, P. Steger
    EUROPEAN PSYCHIATRY, 2009, 24
  • [9] Therapeutic drug monitoring (TDM) in neurology
    Contin, Manuela
    Albani, Fiorenzo
    BIOCHIMICA CLINICA, 2014, 38 (03) : 175 - 182
  • [10] Sirolimus therapeutic drug monitoring (TDM)
    Billaud, EM
    Lacroix, C
    Caudron, E
    Guillemain, R
    Antoine, C
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 535 - 535
12345